» Articles » PMID: 27966104

The Impact of the New National Bone Health Alliance (NBHA) Diagnostic Criteria on the Prevalence of Osteoporosis in the USA

Overview
Journal Osteoporos Int
Date 2016 Dec 15
PMID 27966104
Citations 54
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: The purpose of this paper is to estimate the prevalence of osteoporosis in US adults ≥50 years using the NBHA osteoporosis diagnostic criteria.

Methods: Utilizing 2005-2008 data of the National Health and Nutrition Examination Survey (NHANES), we identified participants with osteoporosis with any one of the following: (1) femoral neck or lumbar spine T-score ≤ -2.5; (2) low trauma hip fracture irrespective of BMD or clinical vertebral, proximal humerus, pelvis, or distal forearm fracture with a T-score >-2.5 <-1.0; or (3) FRAX score at the National Osteoporosis Foundation intervention thresholds (≥3% for hip fracture or ≥20% for major osteoporotic fracture). We estimated the prevalence overall and by gender and age.

Results: Our sample included 1948 (54.3%) men and 1639 (45.7%) women. Approximately 12% were 80+ years and 21% were from racial/ethnic minority groups. We estimated that 16.0% (0.8) of men and 29.9% (1.0) of women 50+ years have osteoporosis. The prevalence increases with age to 46.3% in men and 77.1% in women 80+ years. The combination of FRAX score and fractures was the largest contributing factor defining osteoporosis in men (70-79, 88.1%; 80+, 80.1%), whereas T-score was the largest contributing factor in women (70-79, 49.2%; 80+, 43.5%).

Conclusions: We found that 16% of men and 29.9% of women 50+ have osteoporosis based on the NBHA diagnostic criteria. Although the expanded definition increases the prevalence compared to BMD alone-based definitions, it may better identify those at elevated fracture risk in order to reduce the burden of fractures in older adults.

Citing Articles

Osteoporosis in Older Men: Informing Patient Management and Improving Health-Related Outcomes.

Ruggiero C, Caffarelli C, Calsolaro V, Tafaro L, Riuzzi F, Bubba V Drugs Aging. 2025; 42(1):21-38.

PMID: 39775765 DOI: 10.1007/s40266-024-01163-4.


Comparative effectiveness of four techniques for identifying vertebral fragility fractures among elderly patients.

Ma H, Zhang R, Zhou L, Wang Y, Wang J, Shen C Eur Radiol. 2024; .

PMID: 39699672 DOI: 10.1007/s00330-024-11292-4.


Association between inflammation-related indicators and vertebral fracture in older adults in the United States: A cross-sectional study based on National Health and Nutrition Examination Survey 2013-2014.

Gou Y, Xie X, Yin H, Wu Y, Wen Y, Zhang Y Immun Inflamm Dis. 2024; 12(11):e70047.

PMID: 39508685 PMC: 11542303. DOI: 10.1002/iid3.70047.


Causal relationship between reproductive factors and female bone density: a univariate and multivariate mendelian randomization study.

Lin X, Zuo Y, Hu H, Zhou J Front Genet. 2024; 15:1393106.

PMID: 39346779 PMC: 11427258. DOI: 10.3389/fgene.2024.1393106.


Knowledge, Attitudes, and Practices of Patients with Knee Osteoarthritis Regarding Osteoporosis and Its Prevention: A Cross-Sectional Study in China.

Wu Y, Xu Z, Dong J, Zhang W, Li J, Ji H Int J Gen Med. 2024; 17:3699-3709.

PMID: 39219673 PMC: 11363913. DOI: 10.2147/IJGM.S471924.


References
1.
Cosman F, de Beur S, LeBoff M, Lewiecki E, Tanner B, Randall S . Clinician's Guide to Prevention and Treatment of Osteoporosis. Osteoporos Int. 2014; 25(10):2359-81. PMC: 4176573. DOI: 10.1007/s00198-014-2794-2. View

2.
Siris E, Chen Y, Abbott T, Barrett-Connor E, Miller P, Wehren L . Bone mineral density thresholds for pharmacological intervention to prevent fractures. Arch Intern Med. 2004; 164(10):1108-12. DOI: 10.1001/archinte.164.10.1108. View

3.
Schousboe J, Ensrud K . Diagnostic criteria for osteoporosis should not be expanded. Lancet Diabetes Endocrinol. 2015; 3(4):236-8. DOI: 10.1016/S2213-8587(15)00050-9. View

4.
Wainwright S, Marshall L, Ensrud K, Cauley J, Black D, Hillier T . Hip fracture in women without osteoporosis. J Clin Endocrinol Metab. 2005; 90(5):2787-93. DOI: 10.1210/jc.2004-1568. View

5.
. Osteoporosis prevention, diagnosis, and therapy. NIH Consens Statement. 2001; 17(1):1-45. View